HROW - Why Is Eyecare-Focused Harrow Health Stock Trading Lower Today? | Benzinga
Harrow Health Inc (NASDAQ: HROW) reported Q3 revenues of $34.3 million, an increase of 50% Y/Y, missing the consensus of $37.58 million.
Mark Baum, CEO, commented, During the third quarter, we produced record revenues, a 50% increase over prior?year revenues. However, operationally, the third quarter was a mixed bag, with some areas performing exceptionally well, like our launch of IHEEZO, and some areas underperforming, such ...